Loading...

PRTA PROTHENA CORP PUBLIC LTD CO Business Restructuring 8-K Filing

PRTH

PRT

PROTHENA CORP PUBLIC LTD CO

(PRTA)

2025 8-K

Show Summary

Show Summary

Management Changes

Product Expansion

Product Discontinuation

Financial Statements

Financial Results

Director Resignation

Q3 Financial Results

Management Change

Financial Results Announcement

Annual Meeting Approval

Earnings Reports

Appointment of Director

Earnings Release

Financial Update

Earnings Release

Earnings Release

Annual Meeting Approval

Appointment of Director

Earnings Release

Resignation of Director

Regulation FD Disclosure

Earnings Report

External Links:

On June 18, 2025, Prothena Corp announced a 63% workforce reduction to cut operating costs following the decision to stop developing birtamimab, expecting to incur $16 to $20 million in severance and related costs. Key executives, including the Chief

AI Assistant

PROTHENA CORP PUBLIC LTD CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.